A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT03951753 · COMPLETED
Trial details
- NCT number
- NCT03951753
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-28
- Primary completion
- 2021-04-08
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.